MediFind found 34 doctor with experience in Retinitis Pigmentosa near Baltimore, MD. Of these, 25 are Experienced, 6 are Advanced, 1 are Distinguished and 1 are Elite.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.
The Johns Hopkins Hospital
Mandeep S. Singh, M.D., Ph.D., is associate professor of ophthalmology and genetic medicine in the Retina Division of the Wilmer Eye Institute and the recipient of the 2023 Andreas C. Dracopoulos Professorship in Ophthalmology. Dr. Singh is a retinal specialist. He is Co-Director of the Genetic Eye Disease (GEDi) Center, and is a principal investigator at the Center for Stem Cells and Ocular Regenerative Medicine (STORM). Dr. Singh completed his medical degree at the National University of Singapore. In 2009, he was elected to the Fellow of the Royal College of Surgeons of Edinburgh. He earned a PhD in ophthalmology from the University of Oxford, United Kingdom, in 2014. He completed fellowships in vitreoretinal diseases and surgery at the Oxford Eye Hospital and Moorfields Eye Hospital, both in the United Kingdom. His clinical expertise includes surgical, medical and genetic conditions of the retina and macula. Dr. Singh is specialty-trained in vitrectomy surgery for retinal detachment, macular holes, macular pucker, epiretinal membrane, proliferative vitreoretinopathy, complex retinal detachments including reoperations, vitreous hemorrhage removal, and other retinal surgeries. He also specializes in age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion, and choroidal neovascularization. Dr. Singh sees patients and families with genetic retinal diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and macular dystrophies. His research focus is retinal stem cell transplantation. Dr. Singh’s work has been recognized through the Eye Institute–Allergan Research Prize, the Merton College University of Oxford Graduate Prize Scholarship, the Oxford Ophthalmological Congress Founder’s Cup and Medal, the Ruskell Medal, the Johns Hopkins Clinician Scientist Award, and the Bert M. Glaser, MD Award for Innovative Research in Retina. He is a member of the American Academy of Ophthalmology and the Association for Research in Vision and Ophthalmology. He is also a member of the Club Jules Gonin and the Macula Society. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Singh_CV.pdf. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Leber Congenital Amaurosis, Sorsby Fundus Dystrophy, Usher Syndrome Type 2A, and Doyne Honeycomb Retinal Dystrophy.
The Johns Hopkins Hospital
Mustafa Iftikhar, M.D., is the Stephen J. Ryan Assistant Chief of Service and assistant professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Iftikhar completed his ophthalmology residency at Wilmer, followed by a vitreoretinal surgery fellowship at Duke University Hospital. His clinical approach is rooted in patient-centered and evidence-based care. Dr. Iftikhar’s research interests include retinal diseases, ocular trauma, and healthcare disparities. He is deeply committed to surgical education and takes great pride in mentoring the next generation of ophthalmologists. Dr. Iftikhar is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.
Are you looking for a specific type of Retinitis Pigmentosa?
Common conditions include: X-Linked Retinitis Pigmentosa (XLRP)
The Johns Hopkins Hospital
Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.
The Johns Hopkins Hospital
James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.
The Johns Hopkins Hospital
Cindy X. Cai, M.D., is the Jonathan and Marcia Javitt Rising Professor of Ophthalmology and a retina specialist seeing patients at the Wilmer Eye Institute’s locations in the Baltimore, Maryland area. Her primary focuses are in medical and surgical retina treatments, including: diabetic retinopathy, diabetic macular edema, age-related macular degeneration, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane, and macular hole, among others. Dr. Cai graduated summa cum laude with a major in biology at Columbia University and received her M.D. from the Columbia University College of Physicians and Surgeons in New York. She completed her medical internship at Mercy Medical Center in Baltimore and her ophthalmology residency training at the Wilmer Eye Institute. She received her vitreoretinal surgery fellowship training at Duke Eye Center. Videos Dr. Cindy X. CaiOphthalmologist and Retina Specialist Recent News Articles and Media Coverage Continuing the Mission, Johns Hopkins Medicine (Dec. 2021) Get to Know Cindy Cai, Wilmer Insider (Apr. 2021). Dr. Cai is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Gyrate Atrophy of the Choroid and Retina, Vitrectomy, and Cataract Removal.
The Johns Hopkins Hospital
Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.
The Johns Hopkins Hospital
Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.
The Johns Hopkins Hospital
Ishrat Ahmed, M.D., Ph.D., is an assistant professor of ophthalmology in the Retina Division of the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Ahmed received her combined medical degree and doctoral degree in neuroscience at the Johns Hopkins University School of Medicine in 2017. She is also an alumna of the Wilmer 2021 ophthalmology residency program. Most recently, Dr. Ahmed completed a vitreoretinal surgical fellowship at Massachusetts Eye and Ear in Boston. Dr. Ahmed specializes in the management of macular degeneration, diabetic retinopathy, retinal tears, retinal vein occlusion and other vascular diseases of the retina. She also specializes in the surgical management of retinal detachments, retinal trauma, macular holes, and epiretinal membranes, among others. With a research background in neurodegeneration, Dr. Ahmed has a clinical and research interest in inherited retinal diseases. Dr. Ahmed is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Retinal Detachment, Endophthalmitis, Age-Related Macular Degeneration (ARMD), and Glaucoma.
Donald Zack is an Ophthalmologist in Baltimore, Maryland. Dr. Zack is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, and Trabeculectomy.
Johns Hopkins Bayview Medical Center
Elia J. Duh, M.D., is the G. Edward and G. Britton Durell Professor of Ophthalmology at the Wilmer Eye Institute. He has a joint appointment in the Department of Chemical and Biomolecular Engineering, The Whiting School of Engineering. He specializes in diseases of the retina, including diabetic retinopathy and age-related macular degeneration. In addition to his clinical practice, Dr. Duh actively researches the molecular mechanisms underlying diabetic retinopathy and macular degeneration, particularly the process of ocular neovascularization and excessive retinal vascular permeability. His research has helped determine the role of the major antioxidant regulator, Nrf2, in retinal diseases, and also connected Nrf2 to lifespan. His work has also provided insights into the involvement of the eye in COVID-19. Dr. Duh’s interest in developing new treatments for retinal diseases includes nanomedicine approaches for targeted drug delivery to the eye. Dr. Duh graduated summa cum laude from Yale University and obtained his medical degree from Harvard Medical School. He completed his ophthalmology residency and medical retina fellowship at the Wilmer Eye Institute. He was elected to the American Society of Clinical Investigation in 2016. Dr. Duh is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Vitrectomy.
George Agritellis is an Ophthalmologist in Baltimore, Maryland. Dr. Agritellis is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Cataract, Meibomianitis, Glaucoma, and Eyelid Bump. Dr. Agritellis is currently accepting new patients.
Katzen Medical Associates PC
Jonathan Katz is an Ophthalmologist in Baltimore, Maryland. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Glaucoma, Cataract, Ocular Hypertension (OHT), and Pigment-Dispersion Syndrome. Dr. Katz is currently accepting new patients.
University Of Maryland Eye Associates, P.A.
Kenneth Taubenslag is an Ophthalmologist in Baltimore, Maryland. Dr. Taubenslag is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Endophthalmitis, Neuroretinitis, Uveitis, Trabeculectomy, and Vitrectomy. Dr. Taubenslag is currently accepting new patients.
University Of Maryland Eye Associates, P.A.
Lisa Schocket is an Ophthalmologist in Baltimore, Maryland. Dr. Schocket is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration. Dr. Schocket is currently accepting new patients.
Marco Mura is an Ophthalmologist in Baltimore, Maryland. Dr. Mura is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinal Detachment, Knobloch Syndrome, Pulmonary Fibrosis, Vitrectomy, and Cataract Removal.
Ronald Richter is an Ophthalmologist in Baltimore, Maryland. Dr. Richter is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Cone Dystrophy, and Cone-Rod Dystrophy.
Hendrik Scholl is an Ophthalmologist in Baltimore, Maryland. Dr. Scholl is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Usher Syndrome Type 2A, Usher Syndrome, Cone-Rod Dystrophy, and Doyne Honeycomb Retinal Dystrophy.
Physicians Eye Care Center LLC
Marjorie Warden is an Ophthalmologist in Baltimore, Maryland. Dr. Warden is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Cataract, Interstitial Keratitis, Chalazion, and Eyelid Bump. Dr. Warden is currently accepting new patients.
Greater Baltimore Medical Center Inc
Janet Sunness is an Ophthalmologist in Baltimore, Maryland. Dr. Sunness is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Stargardt Macular Degeneration, Geographic Atrophy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD). Dr. Sunness is currently accepting new patients.
Last Updated: 01/09/2026









